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Although arsenic is a human carcinogen, the molecular mechanisms of its action remain to be understood.
The present study reports that exposure to arsenic induced actin filament reorganization, resulting in lamellipodia and filopodia structures through the activation
of Cdc42 in SVEC4-10 endothelial cells. It was also found
that arsenic induced the formation of the superoxide
anion (O2. ) in SVEC4-10 cells. Immunoprecipitation and
Western blotting analysis demonstrated that arsenic
stimulation induced serine phosphorylation of p47phox,
a key component of NADPH oxidase, indicating that
arsenic induces O2. formation through NADPH oxidase
activation. Inhibition of arsenic-induced actin filament
reorganization by either overexpression of a dominant
negative Cdc42 or pretreatment of an actin filament
stabilizing regent, jasplakinolide, abrogated arsenic-induced NADPH oxidase activation, showing that the activation of NADPH oxidase was regulated by Cdc42-mediated actin filament reorganization. This study also
showed that overexpression of a dominant negative
Rac1 was sufficient to abolish arsenic-induced O2. production, implying that Rac1 activities are required for
Cdc42-mediated NADPH oxidase activation in response
to arsenic stimulation. Furthermore, arsenic stimulation induced cell migration, which can be inhibited by
the inactivation of either Cdc42 or NADPH oxidase.
Taken together, the results indicate that arsenic is able
to activate NADPH oxidase through Cdc42-mediated
actin filament reorganization, leading to the induction of an increase in cell migration in SVEC4-10
endothelial cells.

Arsenic has long been considered a toxic and carcinogenic
metal. There is substantial evidence indicating that the exposure of humans to arsenic via contaminated air and drinking
water causes cancer (1). Both epidemiologic and clinical studies
indicated that arsenic exposure is linked to the high incidence
of skin, bladder, liver, kidney, and lung cancers, as well as
other human diseases (2). Arsenic has been shown to induce
carcinogenesis in vivo by inducing a wide spectrum of changes
in cell signal transduction, including the formation of reactive
oxygen species (ROS),1 an increase in tyrosine phosphoryla* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
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tion, the activation of mitogen-activated protein kinase and
NF-B pathways, alterations in cell differential and proliferation, and the induction of apoptosis (3).
ROS is a collective term for the intermediates formed during
oxidative metabolism, encompassing both oxygen radicals and
non-radical reactive oxygen derivatives including superoxide
anion (O2. ), the hydroxyl radicals (䡠OH), and hydrogen peroxide
(H2O2). Mammalian cells have the antioxidant defense systems
to remove low physiological concentrations of ROS. However,
extremely high concentrations of ROS can cause DNA, protein,
and lipid damage in cells. It has been proven that arsenic
induces the formation of O2. in several different kinds of cells,
including vascular endothelial cells (4), human vascular
smooth muscle cells (5), acute promyelocytic leukemia cells (6),
murine keratinocytes (7), and chronic lymphocytic leukemia
cells (8). It has been proposed that ROS generated by arsenicmediated reactions cause DNA damage, lipid peroxidation, and
protein modification as well as alterations of antioxidant defenses, which are associated with the alterations of cell signal
transduction (3). Although increasing evidence shows that ROS
play an important role in arsenic-induced carcinogenesis, its
mechanism of formation remains to be investigated. Recent
study has demonstrated that arsenic is able to up-regulate
NADPH oxidase, which is the main source of arsenic-induced
ROS generation (9). The mechanism of arsenic-induced
NADPH oxidase activation itself is not clear.
Actin is one of the most abundant proteins in eukaryotic
cells. There are two different forms of actin, mono-actin (Gactin) and actin filaments (F-actin). Actin filaments are involved in a wide variety of cell functions, including cell motility,
cell surface remodeling, cell shape changes during mitosis, cell
contraction and separation during cytokinesis, cell-cell/cellsubstrate interaction, cell signal transduction, angiogenesis,
and endocytosis (10 –12). Actin filaments function in cellular
processes by undergoing dynamic structural reorganization or
remodeling to form discrete structures at the cell periphery
that mediate attachment to the substratum (13). These discrete
structures are lamellipodia, filopodia, membrane ruffles, and
stress fibers (13). The formation of these structures is regulated
by both extracellular and intracellular signals and is essential
for cell adhesion, migration, and signal transduction (11, 13).
Understanding arsenic-induced actin filament reorganization is important for elucidation of the overall mechanisms
involved in arsenic-induced cellular injury. It is controversial

Cdc42/Rac interactive binding region; Cdc42DN, dominant negative
form of Cdc42 cells; DPI, diphenyleneiodonium; FITC, fluorescein isothiocyanate; GST, glutathione S-transferase; TRITC, tetramethylrhodamine isothiocyanate; WASP, Wiskott-Aldrich syndrome protein.
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as to whether the exposure of cells to arsenic will induce actin
filament reorganization. Earlier reports indicated that arsenic
exposure induces the dissociation of actin stress fibers and
membrane perturbations in 3T3 cells (14, 15). There is also a
report showing that arsenic is unable to induce actin filament
reorganization even at such a high concentration that causes a
marked retardation of cell growth in Chinese hamster V79 lung
fibroblast cells (16). Moreover, the molecular mechanisms by
which arsenic induces actin filament reorganization have not
been elucidated, and little is known about the functional implications of arsenic-induced actin filament reorganization in
cell signal transduction and cell metastasis.
In this report, we sought to examine whether arsenic exposure would induce actin filament reorganization in SVEC4-10
endothelial cells and determine the underlying mechanisms
involved. The present study also attempts to understand the
mechanisms of arsenic-induced NADPH oxidase activation and
cell migration with an emphasis on the involvement of Cdc42
and actin filament reorganization. We demonstrated that arsenic stimulation induced actin filament reorganization to form
lamellipodia and filopodia structures through the activation of
Cdc42 in SVEC4-10 endothelial cells. We also found that arsenic stimulation produced superoxide anion (O2. ) and activated
NADPH oxidase, indicating that arsenic may induce O2.
through the activation of NADPH oxidase. Furthermore, we
showed that the activation of NADPH oxidase was regulated by
Cdc42-mediated actin filament reorganization upon arsenic
stimulation. We also demonstrated that Rac activities were
required for Cdc42-mediated O2. production. Interestingly, the
results obtained here also showed that the NADPH oxidase
activity was involved in arsenic-stimulated cell migration via
Cdc42-mediated actin filament reorganization in SVEC4-10
endothelial cells. This study defined a unique cell-signaling
pathway that may be involved in arsenic-induced carcinogenesis. The results of this study also provided the first evidence
showing that Cdc42-induced actin filament reorganization mediates the activation of NADPH oxidase.
EXPERIMENTAL PROCEDURES

Materials—Dulbecco’s modified Eagle’s medium, FITC-phalloidin,
diphenyleneiodonium (DPI), TRITC-phalloidin, FITC-anti-mouse antibody, arsenite, nitro blue tetrazolium, N,N-dimethylformamide, superoxide dismutase, Tiron (4,5-dihydoxy-1,3-benzene disulfonic acid), and
cytochalasin D were purchased from Sigma. Jasplakinolide was purchased from Calbiochem. Anti-phospho-serine antibody was purchased
from Zymed Laboratories Inc.. The anti-p47phox and anti-p67phox antibodies were both purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). The anti-Cdc42 antibody was purchased from BD Biosciences. The anti-c-Myc monoclonal antibody was purchased from Cell
Signaling Technology (Beverly, MA). Dihydroethidium was purchased
from Molecular Probes (Eugene, OR).
Cell Culture and Plasmid Construction—SVEC4-10 cells, an immortal mouse endothelial cell line, were purchased from the American Type
Culture Collection (Manassas, VA) and routinely passaged in Dulbecco’s modified Eagle medium with 10% fetal calf serum. Both a dominant
active form of Cdc42 (phEFdpCdc42V12) and a dominant negative form
of Cdc42 (phEFdnCdc42N14) were gifts from Dr. Alan Hall (University
College London, UK) and Dr. Wang Lu-Hai (Mount Sinai School of
Medicine, New York NY). pGST-PAK-CRIB is a gift from Dr. Pontous
Aspenstrom (Ludwig Institute for Cancer Research, Uppsala, Sweden).
Both phEFdnCdc42N14 and phEFdpCdc42V12 were transfected into
SVEC4-10 cells with Lipofectin (Invitrogen), and the transfected cells
were selected by G-418 to make stable transfected cell lines.
Immunofluorescence Assay—SVEC4-10 cells were grown on coverslips. After treatment, cells were fixed and permeabilized as described
previously (17), followed by labeling with FITC-phalloidin for 30 min
and mounting to the slides with Fluoromount (Fisher, Pittsburgh, PA).
A Zeiss LSM 510 microscope was used to obtain images. Scale bars were
generated and inserted by LSM software.
Wound Healing Assay—The wound healing assays were performed
according to the methods described previously (10, 12). SVEC4-10 cells
were grown on coverslips to 100% confluent monolayers and then

scratched to form a 100-m “wound” using sterile pipette tips. The cells
were then cultured with the different treatments in serum-free media
for 8 –12 h, fixed on coverslips with formalin, and stained with TRITCphalloidin. A Zeiss LSM 510 microscope was used to obtain images.
Scale bars were generated and inserted by LSM software.
Cdc42 Activation Assay—Cdc42 activation assays were performed
according to the method described by Edlund et al. (18). Briefly, the cells
were washed with 1⫻ phosphate-buffered saline supplemented with 1
mM MgCl2. After washing, the cells were lysed immediately with lysis
buffer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl2, 10 g/ml aprotinin, and
1 mM phenylmethylsulfonyl fluoride). The lysates were centrifuged at
14,000 rpm for 15 min. The supernatants were added with GST-WASPCRIB in GST beads to pull-down active Cdc42 proteins, followed by
incubation at 4 °C for 20 min. After incubation, the beads were washed
two times with cold wash buffer (50 mM Tris-HCl pH 7.5, 1% Triton
X-100, 150 mM NaCl, 10 mM MgCl2, 10 g/ml aprotinin, and 0.1 mM
phenylmethylsulfonyl fluoride). The Cdc42 protein was eluted with
sample buffer and subjected to electrophoresis on a 15% SDS-polyacrylamide gel. The Western blot analysis was performed using anti-Cdc42
polyclonal antibody. Protein bands were visualized with an enhanced
chemiluminescence reagent (Amersham Biosciences).
Superoxide Anion (O2.) Assay in Adherent Cells—SVEC4-10 cells
were serum-starved overnight and then stimulated with 10 M arsenic
for different periods of time. During the stimulation periods, dihydroethidium was added at a final concentration of 5 M for 30 min. After
incubation, the cells were washed two times with phosphate-buffered
saline and mounted on coverslips. A Zeiss LSM 510 microscope was
used to obtain images. Scale bars were generated and inserted by
LSM software.
p67phox Translocation Assay—The p67phox protein translocation assay was performed according to the methods described by Zang et al.
(19) and Zhao et al. (20). Briefly, the cells were sonicated for 4 s and
then centrifuged at 100,000 ⫻ g for 1 h to pellet membrane fraction in
the homogenization buffer (20 mM Tris-HCl, 10 mM EGTA, 2 mM EDTA,
2 mM dithiothreitol, and protease inhibitors). After centrifugation, the
membrane fraction (pellet) was resuspended in the homogenization
buffer with 1% Triton X-100. The suspended mixture was sonicated for
4 s and then centrifuged at 15,000 ⫻ g for 15 min. The membrane
proteins were in the supernatants that were analyzed by Western
blot assays.
Measurement of NADPH Oxidase Activities—Measurement of the
activity of NADPH oxidase was performed according to the method
described by Dib et al. (21). Briefly, the cells were incubated with 0.2%
nitro blue tetrazolium during the last 10 min of the incubation. After
the treatment, the adherent cells were scraped off and pelleted. The
pellets were then resolved in N,N-dimethylformamide, and the supernatants were used in measuring the activities of NADPH oxidase with
a spectrophotometer (515 nm).
RESULTS

Arsenic Stimulation Induces Actin Filament Reorganization
in SVEC4-10 Cells—Actin filaments play major roles in cell
signal transduction and carcinogenesis. They have been indicated as being the targets for injury by the epigenetic carcinogenic metal compounds in the environment (14). Arsenic is a
toxic heavy metal that can induce stress-related cell signal
transduction. We sought to clarify whether arsenic stimulation
would induce actin filament reorganization. SVEC4-10 cells, an
immortalized endothelial cell line, were serum-starved overnight and stimulated with 10 M arsenic for different periods of
time ranging from 3 min to 4 h. After the stimulation, the cells
were immediately fixed, permeabilized, and stained with FITCphalloidin, followed by morphological analysis of the cells using
confocal microscopy. The unstimulated SVEC4-10 cells
stretched out evenly, and no protrusions were found at the
leading edge of the cells. The actin filaments were well organized, and few cell motile structures and rosette-like dots were
found at the cell leading edge and cell body, respectively, indicating that the unstimulated SVEC4-10 cells do not undergo a
significant reorganization of actin filaments (Fig. 1A). Upon
stimulation with 10 M arsenic for 3 min, the cell morphology
was changed, and the actin filaments were remodeled (Fig. 1B).
The cells began to round up. There were some actin protrusion
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FIG. 1. Arsenic stimulation induces
actin filament reorganization in
SVEC4-10 cells. SVEC4-10 cells were
grown on coverslips and serum-starved
overnight. The cells were stimulated with
10 M arsenic for different periods of time
as indicated (A–F). After stimulation, the
cells were fixed, permeabilized, and
stained with FITC-phalloidin for actin filaments. Confocal microscopy analysis
was performed to analyze the integrity of
actin filaments.

structures at the leading edge of the cells. These protrusion
structures are lamellipodia and filopodia. Some of the actin
stress fibers were dissociated to form rosette-like structures
around the cell body. These morphological changes indicate
that the actin filaments were reorganized upon arsenic stimulation within 3 min in SVEC4-10 endothelial cells. After the
stimulation with arsenic for 10 –30 min, a substantial number
of lamellipodia and filopodia were found at the leading edge of
the cells, and actin stress fibers were further dissociated, indicating that the actin filaments underwent a more profound
reorganization (Fig. 1, C and D). Arsenic-induced actin filament reorganization lasted for ⬎4 h (Fig. 1, E and F). Dose-dependent experiments demonstrated that the lowest concentration of arsenic that could induce the reorganization of actin
filaments within 30 min of stimulation was 10 M (data not
shown). Our results demonstrated that arsenic stimulation was
sufficient to induce actin filament reorganization to form lamellipodia and filopodia structures at the leading edge of the
cells and rosette-like structures in the cell body in SVEC4-10
endothelial cells, indicating that actin cytoskeleton architecture is a molecular target of arsenic-induced stress injury in
endothelial cells.
Arsenic Stimulation Induces Actin Filament Reorganization
through the Activation of Cdc42—The reorganization of actin
filaments is tightly regulated during cell signal transduction.
To investigate whether arsenic stimulation would activate the
small Rho GTPases Rac and Cdc42, the main actin filament
regulatory proteins (13), SVEC4-10 cells were stimulated with
10 M arsenic for various periods of time ranging from 3 min to
4 h, and the cell lysates were subject to glutathione S-transferase fusion protein pull-down assays using GST-PAK-CRIB
and GST-WASP-CRIB, respectively. Our results demonstrated
that arsenic stimulation induced the activation of Cdc42 within
3 min, and the activation lasted ⬃1 h (Fig. 2A). No Rac activation was found (data not shown).
We then examined whether the activation of Cdc42 regulated
arsenic-induced actin filament reorganization. A dominant
negative form of Cdc42 was stably expressed into SVEC4-10
cells (SVEC-Cdc42DN) to inhibit the activity of Cdc42. Both
SVEC4-10 cells and SVEC-Cdc42DN were stimulated with 10
M arsenic for 30 min, and immunofluorescence assays were

performed to analyze the integrity of actin filaments. The results showed that the inhibition of Cdc42 activity abrogated
arsenic-induced actin filament reorganization (Fig. 2B). Taken
together, the results demonstrated that arsenic-induced actin
filament reorganization was regulated by the activation of
Cdc42 in SVEC4-10 cells.
Arsenic Stimulation Induces NADPH Oxidase Activation—
Using confocal microscopy, we sought to determine whether
stimulation with arsenic would induce the production of O2. in
SVEC4-10 endothelial cells. SVEC4-10 cells were stimulated
with 10 M arsenic for different periods of time and then
examined for the production of O2. by staining the cells with 5
M dihydroethidium during the last 30 min of stimulation.
Dihydroethidium stains cells a blue color, which can be detected by confocal microscopy. When degraded by O2. , the dye
changes color from blue to red. The red color was shown on the
left side of each panel in Fig. 3, whereas the blue color was
shown on the right side of each panel. Our results showed that
the unstimulated SVEC4-10 cells exhibited the blue color and
little or no red color (Fig. 3A, section 1), demonstrating that the
unstimulated cells do not generate substantial amounts of the
O2. radical. Upon arsenic stimulation for 3 min, the blue color
disappeared, and the cells were stained to a red color (Fig. 3A,
sections 2–5), demonstrating the production of the O2. radical.
The arsenic-induced red color peaked at 30 min and lasted at
least 4 h after stimulation. Our results indicate that arsenic
stimulation induces the production of O2. in SVEC4-10 endothelial cells.
NADPH oxidase is one of major enzymes that are involved in
O2. production (22). It was demonstrated that arsenic stimulation
activated NADPH oxidase in endothelial cells (23). We sought to
determine whether arsenic-induced O2. production is through the
activation of NADPH oxidase in SVEC4-10 cells. Serine phosphorylation of p47phox is an essential step in the activation of
NADPH oxidase, and the induction of p47phox phosphorylation in
serines is a strong indication of NADPH oxidase activation (22).
We performed both immunoprecipitation and Western blotting
assays using anti-p47phox and anti-phosphoserine antibodies to
determine whether arsenic would stimulate serine phosphorylation of p47phox in SVEC4-10 cells. The results showed that arsenic stimulation induced an increase in serine phosphorylation
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FIG. 2. Arsenic stimulation (Arn) induces actin filament reorganization
through the activation of Cdc42 in
SVEC4-10 cells. A, arsenic stimulation
induces the activation of Cdc42.
SVEC4-10 cells were serum-starved overnight and then stimulated with 10 M
arsenic for different periods of time as
indicated. The cells were lysed after the
stimulation, and the lysates were subjected to GST-WASP-CRIB pull-down assays to analyze the activities of Cdc42.
The reactions of the pull-down assays
were resolved by electrophoresis on a 15%
SDS-polyacrylamide gel, and an antiCdc42 antibody was used to detect Cdc42.
B, arsenic stimulation induces actin filament reorganization through the activation of Cdc42. Both SVEC4-10 cells and
SVEC-Cdc42DN cells were grown on coverslips and serum-starved overnight. The
cells were stimulated with 10 M arsenic
for 30 min. After the stimulation, the cells
were fixed, permeabilized, and stained
with FITC-phalloidin for actin filaments.
Confocal microscopy analysis was performed to analyze the integrity of actin
filaments.

of p47phox within 3 min, and the peak of the serine phosphorylation occurred ⬃30 min after the stimulation. The phosphorylation lasted ⬎4 h (Fig. 3B). The data presented here demonstrated
that arsenic stimulation induced the activation of NADPH oxidase in SVEC4-10 endothelial cells. Moreover, the profile of arsenic-induced serine phosphorylation of p47phox is similar to that
of arsenic-induced O2. production, indicating that NADPH oxidase is a major enzyme that produces O2. upon arsenic stimulation in SVEC4-10 endothelial cells. To further prove arsenicinduced activation of NADPH oxidase, we performed a p67phox
translocation assay. The results showed that p67phox was translocated to the cell membrane fraction upon arsenic stimulation
(Fig. 3C), which is one of hallmarks of NADPH oxidase activation
(22). Taken together, the results demonstrated that arsenic induced the activation of NADPH oxidase in SVEC4-10 cells.
Arsenic Stimulation Induces NADPH Oxidase Activities
through the Activation of Cdc42 and the Reorganization of Actin
Filaments—The major focus in this section is to investigate how
arsenic stimulation induces the activation of NADPH oxidase in
SVEC4-10 cells. In our previous report, we showed that the
activation of Cdc42 mediated ethanol-induced ROS production in
SVEC4-10 cells (10). The present study investigates whether the
induction of NADPH oxidase activity was mediated by Cdc42
activation upon arsenic stimulation in the same cells. Both
SVEC4-10 cells and SVEC-Cdc42DN cells were stimulated with
10 M arsenic for 30 min, and then the production of superoxideinduced formazan was measured to determine the activity of
NADPH oxidase (21). Our results showed that arsenic stimulation induced an increase in superoxide-induced formazan produc-

tion in SVEC4-10 cells that was abolished by the disruption of
Cdc42 activity, indicating that the activation of Cdc42 mediates
arsenic-induced O2. production in SVEC4-10 cells (Fig. 4A). We
also pretreated the cells with superoxide dismutase, a superoxide-specific scavenger, to examine whether superoxide dismutase
would abrogate the superoxide-induced formazan formation. The
results showed that the pretreatment of superoxide dismutase
inhibited arsenic-induced formation of formazan (Fig. 4A), proving that Cdc42 specifically mediates arsenic-induced O2. production. Immunoprecipitation analysis demonstrated that the
disruption of Cdc42 abrogated arsenic-induced serine phosphorylation of p47phox in SVEC4-10 cells (Fig. 4B), indicating
that Cdc42 regulates NADPH oxidase activation in response to
arsenic stimulation. We further examined whether Cdc42 regulated the activation of NADPH oxidase through the reorganization of actin filaments. SVEC4-10 cells were pretreated with the
actin filament inhibitors jasplakinolide or cytochalasin D, respectively, and were then stimulated with arsenic for 30 min. Jasplakinolide is an inhibitor of actin filament reorganization that
stabilizes actin filaments, and cytochalasin D is an actin filament
inhibitor that disrupts the structures of actin filaments (24).
They induce the opposite morphological changes in actin filaments. Cytochalasin D, to a lesser extent, mimics the effects of
Cdc42 on actin filaments in terms of disruption of actin filament
structure. Our immunoprecipitation and Western blotting analysis showed that pretreatment with jasplakinolide abolished arsenic-induced NADPH oxidase activation, whereas pretreatment
with cytochalasin D only partially inhibited arsenic-induced
NADPH oxidase activation (Fig 4B), indicating that Cdc42-me-
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FIG. 3. Arsenic stimulation activates NADPH oxidase in SVEC4-10
cells. A, arsenic stimulation induces the
production of O2. . SVEC4-10 cells were
grown on coverslips and serum-starved
overnight. The cells were stimulated with
10 M arsenic for different periods of time
as indicated (sections 1–5). Dihydroethidium (5 M) dye was added into the
cell culture during the last 30 min of the
stimulation. After staining, the cells were
fixed and analyzed by confocal microscopy. B, arsenic stimulation induces the
serine phosphorylation of p47phox in
SVEC4-10 cells. SVEC4-10 cells were serum-starved overnight and stimulated
with 10 M arsenic for different periods of
time as indicated. After stimulation, the
cells were lysed and the lysates were immunoprecipitated (IP) with an antip47phox antibody. The immunoprecipitation
reactions
were
resolved
by
electrophoresis on a 10% SDS-polyacrylamide gel, followed by Western blotting
analysis using an anti-phosphoserine antibody. The densitometries of p47phox
phosphorylation were scanned using
EGII software, and the results were plotted by SigmaPlot. C, arsenic stimulation
induces p67phox translocation. SVEC4-10
cells were serum-starved overnight and
stimulated with 10 M arsenic for different periods of time as indicated. After
stimulation, the cells underwent the protein translocation assay. The cell membrane fractions were resolved by electrophoresis on an 8% SDS-polyacrylamide
gel followed by the Western blotting analysis using an anti-p67phox antibody. The
densitometries of p67phox were scanned
using EGII software, and the results were
plotted by SigmaPlot.
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FIG. 4. Arsenic-induced activation (Arn) of NADPH oxidase is regulated by Cdc42-mediated actin filament reorganization. A,
arsenic stimulation activates NADPH oxidase through Cdc42. Both SVEC 4-10 cells and SVEC-Cdc42DN cells were preincubated with 0.1% nitro
blue tetrazolium and then treated with 10 M arsenic for 30 min as indicated. Both SVEC4-10 cells alone and SVEC4-10 cells with superoxide
dismutase (SOD) pretreatment (500 units/ml/h) were set as the negative controls. After the treatments, the cells were lysed, and the supernatants
of the lysates were dissolved in N,N-dimethylformamide. The amount of formazan in the supernatants was detected by a spectrophotometer at 515
nm, which represents the amount of superoxide formation. The data are from three independent experiments. An asterisk indicates a significant
difference from controls (p ⬍ 0.01, n ⫽ 3). B, arsenic-induced increase in serine phosphorylation of p47phox is mediated by Cdc42 and actin filament
reorganization. SVEC4-10 cells were pretreated with 1 M cytochalasin D or 100 nM jasplakinolide for 1 h, respectively, as indicated. After the
pretreatments, the cells were stimulated with 10 M arsenic for 30 min. After the stimulation, the cells were lysed, and the lysates were
immunoprecipitated (IP) with an anti-p47phox antibody. The immunoprecipitation reactions were resolved by electrophoresis on a 10% SDSpolyacrylamide gel, followed by the Western blotting analysis using an anti-phospho-serine antibody. The densitometries of p47phox phosphorylation were scanned using EGII software, and the results were plotted by SigmaPlot. C, arsenic stimulation induces superoxide production through
Cdc42 and actin filament reorganization. The cells were grown on coverslips and serum-starved overnight. The cells were pretreated with either
1 M cytochalasin D (CD) or 100 nM jasplakinolide (Jas) for 1 h as indicated and then stimulated with 10 M arsenic for 30 min. Dihydroethidium
(5 M) dye was added into the cell culture during the last 30 min of the stimulation. After the staining, the cells were fixed and analyzed by confocal
microscopy. D, Rac activities are required for arsenic-induced O2. production. Section 1, SVEC4-10 cells were grown on coverslips and transiently
transfected with a dominant negative mutant of Rac1, pRK5mycRacN17. After incubation for 48 h, the cells were fixed and stained with both an
anti-Myc antibody and a FITC-anti-mouse antibody, followed by confocal microscopy analysis. The left side shows pRK5mycRacN17-transfected
cells. The right side shows all the cells visualized under a phase-contrast channel. Section 2, the pRK5mycRacN17-transfected cell lysates were
resolved by electrophoresis on a 12% SDS-polyacrylamide gel followed by the Western blotting with an anti-Myc antibody. Section 3, both
SVEC-RacN17 cells and SVEC4-10 cells were stimulated with 10 M arsenic for 30 min. After the stimulation, the cells were lysed and the lysates
were immunoprecipitated with an anti-p47phox antibody. The immunoprecipitation reactions were resolved by electrophoresis on a 10% SDSpolyacrylamide gel followed by Western blotting analysis using an anti-phosphoserine antibody. Section 4, both SVEC4-10 cells (left) and
SVEC-RacN17 cells (right) were grown on coverslips and serum-starved overnight. After serum starvation, the cells were stimulated with 10 M
arsenic for 30 min. Dihydroethidium (5 M) dye was added into the cell culture during the stimulation. After the staining, the cells were fixed and
analyzed by confocal microscopy.

Arsenic Induces Cell Migration via Cdc42 and NADPH Oxidase

3881

FIG. 4 —continued

diated actin filament reorganization might regulate NADPH oxidase activation in response to arsenic stimulation. To further
prove the effects of actin filament reorganization on NADPH
oxidase activation, the pretreated SVEC4-10 cells were stimulated with arsenic followed by staining with dihydroethidium
dye. SVEC-Cdc42DN cells were set as a negative control. The
results demonstrated that arsenic-induced O2. production was
abolished by either the disruption of Cdc42 activity or the inhibition of actin filament reorganization with jasplakinolide pretreatment (Fig. 4C). The pretreatment of cytochalasin D had a
small effect on arsenic-induced O2. production (Fig. 4C).
Because Rac1 is both a downstream protein of Cdc42 and a
key component of NADPH oxidase, we performed Rac activa-

tion assays to determine whether Rac1 was activated upon
arsenic stimulation in SVEC4-10 cells. Our results demonstrated that no Rac activation was observed (data not shown).
We then performed experiments to examine whether Rac1 activities were required for Cdc42-modulated NADPH oxidase
activation in response to arsenic stimulation. A dominant negative Rac, pRK5mycRacN17, was transiently overexpressed
into SVEC4-10 cells followed by stimulation with 10 M arsenic
for 30 min. After stimulation, the cell lysates were subjected to
immunoprecipitation assays to examine the serine phosphorylation level of p47phox. We also detected the effects of RacN17
overexpression on arsenic-induced O2. production. Our results
showed that ⬎90% of the cells expressed RacN17 after 48 h of
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FIG. 5. Arsenic stimulation (Arn) induces an increase in cell migration. A and B, the cells were grown on coverslips to 100% confluent
monolayers. Sterile pipette tips were used to scratch the confluent monolayer cells to form a 100-m wound, and then the cells were grown for 8 h
with (B) or without (A) 10 M arsenic stimulation as indicated. C, SVEC4-10 cells were stably transfected with a dominant negative form of Cdc42.
D, SVEC4-10 cells were pretreated with 10 M DPI for 1 h. E, SVEC4-10 cells were stably transfected with a dominant active form of Cdc42
(Cdc42DP). F, SVEC-Cdc42DP cells were pretreated with 100 nM jasplakinolide (Jas) for 1 h. G, SVEC4-10 cells were pretreated with superoxide
dismutase (SOD; 500 units/ml) for 1 h. H, SVEC4-10 cells were pretreated with 5 mM Tiron for 1 h.

transfection (Fig. 4D, section 1). The overexpression of RacN17
had no effects on arsenic-induced p47phox serine phosphorylation, indicating that Cdc42-regulated p47phox activation upon
arsenic stimulation is independent of Rac activities (Fig. 4D,
section 2). However, the overexpression of RacN17 was sufficient to abolish arsenic-induced O2. production, implying that
the integrity of Rac activities was required for Cdc42-mediated
NADPH oxidase activation to produce O2. upon arsenic stimulation (Fig. 4D, section 3). Taken together, our results indicate
that the activation of Cdc42 regulates NADPH oxidase activities via the reorganization of actin filaments in response to
arsenic stimulation in SVEC4-10 endothelial cells, which requires Rac activities.
Arsenic Stimulation Induces Cell Migration—Both Cdc42
and actin filaments are the key signal proteins that are involved in cell migration (11, 25). Arsenic-induced changes in
actin filaments and Cdc42 indicate that arsenic may be able to
enhance cell migration in SVEC4-10 cells. We determined
whether arsenic would have the capability to induce cell migration and then investigated whether the increase in cell
migration would be regulated by arsenic-induced changes in
Cdc42, actin filaments, and NADPH oxidase. Cell wound healing assays were performed. SVEC4-10 cells were grown to
100% confluent monolayers on coverslips, starved for serum,
and then scratched to form a 100-m wound with the sterile
pipette tips. After the cells were wounded, they were cultured
for 8 h with or without 10 M arsenic stimulation to examine
the difference of cell motility at the edge of the wound. SVECCdc42DN cells were used as a negative control to determine the
importance of Cdc42 in arsenic-induced cell migration. We also
investigated the requirements for NADPH oxidase activation
in arsenic-induced cell migration via DPI pretreatment of the
cells. DPI is an effective inhibitor of NADPH oxidase (26). Our
results showed that the edge of the wound was smooth and that
the cells at the edge were unable to move toward the wound
without arsenic stimulation after 8 h of the incubation (Fig.
5A), indicating the cells are static in terms of migration. However, upon arsenic stimulation the edge of the wound became
protrusive, and many cells migrated out of the boundary of the
wound to heal the wound (Fig. 5B), showing that arsenic stim-

ulation induces an increase in cell migration. Our results also
showed that either the disruption of Cdc42 activity by
Cdc42DN or the inhibition of NADPH oxidase with DPI abolished arsenic-induced cell migration (Fig. 5, C and D). Furthermore, overexpression of a dominant active form of Cdc42
(SVEC-Cdc42DP) was sufficient to induce an increase in cell
migration, which is totally abolished upon treatment with jasplakinolide (Fig. 5, E and F). Finally, our results demonstrated
that the pretreatment with either 500 units/ml superoxide
dismutase or 5 mM Tiron to inhibit the formation of O2. was
sufficient to abrogate arsenic-induced cell migration (Fig. 5, G
and H), indicating that arsenic-induced cell migration is a
linear consequence of Cdc42 activity and O2. production. Taken
together, the results show that arsenic stimulation induced an
increase in cell migration, which was regulated by Cdc42 and
NADPH oxidase.
DISCUSSION

The concentration of arsenic (10 M) used here is relatively
high compared with the highest concentration of arsenic (2 M)
that humans can tolerate without major side effects (2). However, in most in vitro experiments used to study arsenic-induced cell signal transduction the concentration ranges from
0.1 to 500 M, depending on the duration of the treatment (2).
In general, a high concentration of arsenic for in vitro experiments is needed to induce changes in cell signal transduction in
a relatively short exposure time.
Arsenic is a carcinogen. It is associated with a high incidence
of several types of human cancers (2). However, the molecular
mechanisms by which it induces cancer development have not
been well elucidated. In this study, we sought to investigate
arsenic-induced NADPH oxidase activation and cell migration
with emphasis on the role of Cdc42 and actin filament reorganization. The reorganization of actin filaments is a hallmark of
cell transformation and the main driving force for cell migration, which is directly involved in angiogenesis, cancer invasion, and metastasis. The processes of actin filament reorganization are essential in cell extension, attachment, contraction,
and release during cell movement (27). Our results showed that
arsenic stimulation induced the formation of the cellular pro-
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trusion structures lamellipodia and filopodia at the leading
edges of cells and rosette-like dot structures in the cell body,
which demonstrated that arsenic stimulation was sufficient to
induce the reorganization of actin filaments in SVEC4-10 cells.
The formation of lamellipodia and filopodia involves dynamic
processes of actin filament polymerization and depolymerization and actin filament cross-linking (17, 28). These cell motile
structures are the key features of transformed cells (29, 30).
The reorganization of actin filaments is tightly regulated by
small Rho GTPases, mainly Cdc42 and Rac (13). The results
obtained from the present study demonstrated that arsenicinduced actin filament reorganization was regulated by the
activation of Cdc42. In fibroblast cells, the activation of Cdc42
and Rac is in a hierarchical cascade wherein Cdc42 activates
Rac (13). The increase in the formation of lamellipodia indicates that arsenic stimulation may activate Rac in SVEC4-10
cells. We performed Rac activation assays and found that no
Rac activation was induced upon stimulation with arsenic
(data not shown). It is not unprecedented that Cdc42 remodels
actin filaments to form both lamellipodia and filopodia structures without the activation of Rac. Both our previous study in
SVEC4--10 cells and those from other groups demonstrated
that Cdc42 was able to induce the formation of lamellipodia
independent of the activation of Rac (10, 18, 31).
NADPH oxidase is one of the key enzymes that are involved in the generation of O2. in a variety of cells. It has been
demonstrated that NADPH oxidase is a major source of O2.
production in endothelial cells and that the production of
O2. plays a major role in vascular physiology and pathology
(22, 32). NADPH oxidase is composed of several components,
including p40phox, p67phox, p22phox, gp91phox, and Rac (22). Its
activity is low in static endothelial cells (32). Upon stimulation, it can be activated in several minutes to several hours
(32). One of the key steps of NADPH oxidase activation is the
serine phosphorylation of p47phox. It was demonstrated that
the kinetics of p47phox serine phosphorylation paralleled that
of NADPH oxidase activation (33). p47phox is an essential
part of NADPH oxidase in endothelial cells as well as in
phagocytes. It was found that p47phox⫺/⫺ endothelial cells
were unable to sufficiently produce ROS and transmit signaling upon different stimuli. Overexpression of p47phox into
these p47 knock-out cells rescued the response of agonistinduced O2. generation (32, 34). The results obtained from the
present study have demonstrated that arsenic stimulation of
SVEC4-10 cells generates O2. both extracellularly and intracellularly. The increase in serine phosphorylation of p47phox
indicates that arsenic is able to activate NADPH oxidase and
that this activation is responsible for the arsenic-induced
generation of O2. .
It has been demonstrated that NADPH oxidase activity is
modulated by several enzymes in endothelial cells, including
protein kinase C, phospholipase D, phospholipase A2, phosphatidylinositol 3-kinase, Src, and Rac (32). The present study provided the evidence that NADPH oxidase was regulated by Cdc42.
Interestingly, Rac, which is a downstream of Cdc42 and is a key
component of NADPH oxidase, is not activated in response to
arsenic stimulation, which matches our previous observation
that Cdc42 is able to induce ROS production independent of Rac
activation upon ethanol stimulation in the same cell system (10).
However, our results demonstrated that the integrity of Rac
activities was essential for arsenic-induced O2. production, indicating that Cdc42-mediated O2. production is Rac-dependent. It
was reported that the guanine nucleotide exchange factor Trio
can activate the phagocyte NADPH oxidase in the absence of a
GDP-to-GTP exchange on Rac in an in vitro cell-free NADPH
oxidase assay (35). It has been suggested that a conformational
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change in Rac-GDP upon its interaction with a guanine nucleotide exchange factor is sufficient for mediating NADPH oxidase
activation (35). Overexpression of a dominant negative Cdc42
abrogated arsenic-induced actin filament reorganization and
NADPH oxidase activation, indicating that Cdc42 modulates
both actin filament reorganization and NADPH oxidase activation upon stimulation with arsenic. The present study attempted
to correlate these two cellular responses. Although both cytochalasin D and jasplakinolide are actin filament modifiers, they
induce the opposite morphological changes in actin filaments
through different mechanisms. Cytochalasin D blocks actin polymerization to disrupt actin filament structures, whereas jasplakinolide induces actin polymerization to inhibit actin filament
reorganization (24). Using these two actin filament modifiers, the
present study shows that Cdc42 regulates NADPH oxidase activity through actin filament reorganization in response to arsenic stimulation. Actin filament reorganization has been found
to activate several cell signal proteins, including Erk, JUN, p38,
Rho kinase, and Src (36 – 40). The molecular mechanisms of the
activation have not been elucidated. Actin filaments, as a main
scaffold for cells, not only provide the mechanical supports to cells
but also compartmentalize cellular proteins to localize cellular
signal transduction. The reorganization of actin filaments upon
stimulation may disrupt the actin filament-organized cell compartments and change the cellular localization of signal proteins,
leading to changes in cell signal transduction. p47phox was found
to directly associate with actin filaments in both endothelial cells
and neutrophils (41, 42). Most of p47phox protein and basal
NADPH activities are associated with actin filaments in unstimulated endothelial cells (43). It is possible that the actin
filaments may provide a structural basis to stabilize NADPH
oxidase in static cells. Upon stimulation with arsenic, the reorganized actin filaments may change the localization of p47phox
and enable other cell signal proteins to phosphorylate p47phox.
Indeed, it was found that angiotensin II-induced activation of
endothelial cell NADPH oxidase involved the subcellular redistribution of p47phox (41). It would be interesting to find out which
signal protein(s) are involved in the serine phosphorylation of
p47phox following Cdc42 activation and actin filament reorganization in response to arsenic stimulation.
Arsenic-induced formation of lamellipodia and filopodia indicates that arsenic may have an ability to increase cell migration, which has been demonstrated in the present study. This is
the first evidence showing that arsenic induces cell migration
in endothelial cells. The results obtained further demonstrate
that arsenic induces cell migration through Cdc42-mediated
NADPH oxidase. NADPH oxidase activity was found to mediate endothelial cell migration upon stimulation with growth
factors (44). NADPH oxidase-produced ROS play a major role
in various cell signal transduction pathways, including cell
migration and angiogenesis. Cdc42 has also been demonstrated
to be directly involved in cell migration (25). The present study
also indicates that NADPH oxidase-produced O2. is a mediator
for Cdc42-induced cell migration. The increase in cell migration
upon arsenic stimulation suggests that arsenic may promote
cancer development through the enhancement of cell migration, opening a new door for the investigation of the overall
mechanisms of arsenic-induced carcinogenesis.
Taken together, this study demonstrated that arsenic stimulation is sufficient to do the following: (a) induce the reorganization of actin filaments; (b) induce the activation of Cdc42;
(c) activate NADPH oxidase and generate O2. ; and (d) induce an
increase in cell migration. Our study has also concluded that
Cdc42 is able to regulate NADPH oxidase activity through
actin filament reorganization, leading to an increase in cell
migration in endothelial cells. Our study defines a unique
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FIG. 6. Schematic representation of signal transduction from
arsenic stimulation to cell migration.

signal transduction pathway that indicates Cdc42 mediates
cell migration through actin filament reorganization and
NADPH oxidase activation upon arsenic stimulation in endothelial cells (Fig. 6).
Acknowledgments—We thank Dr. Val Vallyathan for helpful comments. We also thank Yongju Lu for the p67phox translocation assays.

27.
28.
29.
30.
31.
32.
33.
34.

REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.

Hayes, R. B. (1997) Cancer Causes Control 8, 371–385
Bode, A. M., and Dong, Z. (2002) Crit. Rev. Oncol. Hematol. 42, 5–24
Qian, Y., Castranova, V., and Shi, X. (2003) J. Inorg. Biochem. 96, 271–278
Barchowsky, A., Klei, L. R., Dudek, E. J., Swartz, H. M., and James, P. E.
(1999) Free Radic. Biol. Med. 27, 1405–1412
Lynn, S., Gurr, J. R., Lai, H. T., and Jan, K. Y. (2000) Circ. Res. 86, 514 –519
Jing, Y., Dai, J., Chalmers-Redman, R. M., Tatton, W. G., and Waxman, S.
(1999) Blood 94, 2102–2111
Corsini, E., Asti, L., Viviani, B., Marinovich, M., and Galli, C. L. (1999)
J. Investig. Dermatol. 113, 760 –765
Zhou, Y., Hileman, E. O., Plunkett, W., Keating, M. J., and Huang, P. (2003)
Blood 101, 4098 – 4104
Chou, W. C., Jie, C., Kenedy, A. A., Jones, R. J., Trush, M. A., and Dang, C. V.
(2004) Proc. Natl. Acad. Sci. U. S. A. 101, 4578 – 4583
Qian, Y., Luo, J., Leonard, S. S., Harris, G. K., Millecchia, L., Flynn, D. C., and
Shi, X. (2003) J. Biol. Chem. 278, 16189 –16197
Schmidt, A., and Hall, M. N. (1998) Annu. Rev. Cell Dev. Biol. 14, 305–338
Qian, Y., Corum, L., Meng, Q., Blenis, J., Zheng, J. Z., Shi, X., Flynn, D. C., and

35.
36.
37.
38.
39.

40.
41.
42.
43.
44.

Jiang, B. H. (2004) Am. J. Physiol. 286, C153–C163
Hall, A. (1998) Science 279, 509 –514
Chou, I. N. (1989) Biomed. Environ. Sci. 2, 358 –365
Li, W., and Chou, I. N. (1992) Toxicol. Appl. Pharmacol. 114, 132–139
Ochi, T., Nakajima, F., and Fukumori, N. (1998) Arch. Toxicol. 72, 566 –573
Qian, Y., Baisden, J. M., Westin, E. H., Guappone, A. C., Koay, T. C., and
Flynn, D. C. (1998) Oncogene 16, 2185–2195
Edlund, S., Landstrom, M., Heldin, C. H., and Aspenstrom, P. (2002) Mol. Biol.
Cell 13, 902–914
Zang, Q., Frankel, P., and Foster, D. A. (1995) Cell Growth & Differ. 6,
1367–1373
Zhao, Q., Slavkovich, V., and Zheng, W. (1998) Toxicol. Appl. Pharmacol. 149,
99 –106
Dib, K., Melander, F., Axelsson, L., Dagher, M. C., Aspenstrom, P., and
Andersson, T. (2003) J. Biol. Chem. 278, 24181–24188
Babior, B. M. (1999) Blood 93, 1464 –1476
Smith, K. R., Klei, L. R., and Barchowsky, A. (2001) Am. J. Physiol. 280,
L442–L449
Fenteany, G., and Zhu, S. (2003) Curr. Top. Med. Chem. 3, 593– 616
Raftopoulou, M., and Hall, A. (2004) Dev. Biol. 265, 23–32
O’Donnell, B. V., Tew, D. G., Jones, O. T., and England, P. J. (1993) Biochem.
J. 290, 41– 49
Sheetz, M. P., Felsenfeld, D., Galbraith, C. G., and Choquet, D. (1999) Biochem. Soc. Symp. 65, 233–243
Welch, M. D., Mallavarapu, A., Rosenblatt, J., and Mitchison, T. J. (1997)
Curr. Opin Cell Biol. 9, 54 – 61
Cramer, L. P. (1997) Front. Biosci. 2, d260 – d270
Flynn, D. C., Leu, T. H., Reynolds, A. B., and Parsons, J. T. (1993) Mol. Cell.
Biol. 13, 7892–7900
Brown, M. D., Cornejo, B. J., Kuhn, T. B., and Bamburg, J. R. (2000) J. Neurobiol. 43, 352–364
Lassegue, B., and Clempus, R. E. (2003) Am. J. Physiol. 285, R277–R297
Rotrosen, D., and Leto, T. L. (1990) J. Biol. Chem. 265, 19910 –19915
Li, J. M., Mullen, A. M., Yun, S., Wientjes, F., Brouns, G. Y., Thrasher, A. J.,
and Shah, A. M. (2002) Circ. Res. 90, 143–150
Sigal, N., Gorzalczany, Y., Sarfstein, R., Weinbaum, C., Zheng, Y., and Pick, E.
(2003) J. Biol. Chem. 278, 4854 – 4861
Faisal, A., Kleiner, S., and Nagamine, Y. (2004) J. Biol. Chem. 279, 3202–3211
Baisden, J. M., Gatesman, A. S., Cherezova, L., Jiang, B. H., and Flynn, D. C.
(2001) Oncogene 20, 6607– 6616
Yujiri, T., Fanger, G. R., Garrington, T. P., Schlesinger, T. K., Gibson, S., and
Johnson, G. L. (1999) J. Biol. Chem. 274, 12605–12610
Schmid-Alliana, A., Menou, L., Manie, S., Schmid-Antomarchi, H., Millet,
M. A., Giuriato, S., Ferrua, B., and Rossi, B. (1998) J. Biol. Chem. 273,
3394 –3400
Subbaramaiah, K., Hart, J. C., Norton, L., and Dannenberg, A. J. (2000)
J. Biol. Chem. 275, 14838 –14845
Li, J. M., and Shah, A. M. (2003) J. Biol. Chem. 278, 12094 –12100
Tamura, M., Kai, T., Tsunawaki, S., Lambeth, J. D., and Kameda, K. (2000)
Biochem. Biophys. Res. Commun. 276, 1186 –1190
Li, J. M., and Shah, A. M. (2002) J. Biol. Chem., 277, 19952–19960
Abid, M. R., Kachra, Z., Spokes, K. C., and Aird, W. C. (2000) FEBS Lett. 486,
252–256

